MedPath

Sulfate ion

Generic Name
Sulfate ion
Drug Type
Small Molecule
Chemical Formula
O4S
CAS Number
14808-79-8
Unique Ingredient Identifier
7IS9N8KPMG

Overview

No overview information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2025/07/08
Not Applicable
Recruiting
Syed Hamza Mufarrih
2025/03/19
Phase 3
Not yet recruiting
2024/12/19
Not Applicable
Recruiting
Arooj Khan
2024/07/25
N/A
Not yet recruiting
2024/04/16
Phase 3
Recruiting
2024/02/01
Not Applicable
Completed
Fahad Javed Awan
2023/06/28
Phase 3
Recruiting
2022/12/01
Phase 3
Withdrawn
2022/09/16
Phase 2
Active, not recruiting
2022/07/20
Phase 3
Completed

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Healthlife of USA
69517-133
ORAL
65 mg in 1 1
12/20/2017
Carwin Pharmaceutical Associates, LLC
15370-102
ORAL
9.5 mg in 1 mL
4/21/2017
Pangea Pharmaceuticals, LLC
81279-101
ORAL
9.5 mg in 1 mL
12/22/2023
PD-Rx Pharmaceuticals, Inc.
72789-436
ORAL
65 mg in 1 1
5/7/2025
Method Pharmaceuticals, LLC
58657-327
ORAL
10 mg in 1 mL
12/12/2023

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.